FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
1-Year Return
33.17%
This Quarter Return
+19.99%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.24B
AUM Growth
+$190M
(+18%)
Cap. Flow
+$72.4M
Cap. Flow
% of AUM
5.83%
Top 10 Holdings %
Top 10 Hldgs %
53.49%
Holding
86
New
11
Increased
17
Reduced
17
Closed
11
Top Buys
| 1 |
Xenon Pharmaceuticals
XENE
|
$48.1M |
| 2 |
Alphatec Holdings
ATEC
|
$44.5M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$22.8M |
| 4 |
Inspire Medical Systems
INSP
|
$18M |
| 5 |
Biohaven
BHVN
|
$16.4M |
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$32M |
| 2 |
Orthofix Medical
OFIX
|
$23.8M |
| 3 |
Structure Therapeutics
GPCR
|
$18.9M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$18.2M |
| 5 |
Health Catalyst
HCAT
|
$17.7M |
Sector Composition
| 1 | Healthcare | 95.85% |
| 2 | Communication Services | 3.34% |
| 3 | Industrials | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Centene
CNC
$14B
| $410K | 0.03% |
5,521
| – | – |
|
52
Humana
HUM
$37.5B
| $407K | 0.03% |
888
| – | – |
|
53
Fresenius Medical Care
FMS
$14.2B
| $406K | 0.03% |
19,490
| – | – |
|
54
Enovis
ENOV
$1.8B
| $404K | 0.03% |
7,203
| – | – |
|
55
AbbVie
ABBV
$376B
| $394K | 0.03% |
2,540
| – | – |
|
56
Sanofi
SNY
$112B
| $383K | 0.03% |
7,711
| – | – |
|
57
GSK
GSK
$79.6B
| $373K | 0.03% |
10,058
| – | – |
|
58
Gilead Sciences
GILD
$140B
| $367K | 0.03% |
4,526
| – | – |
|
59
Takeda Pharmaceutical
TAK
$48.2B
| $366K | 0.03% |
25,630
| – | – |
|
60
Viatris
VTRS
$12.1B
| $357K | 0.03% |
33,010
| – | – |
|
61
Medtronic
MDT
$120B
| $345K | 0.03% |
4,188
| – | – |
|
62
Johnson & Johnson
JNJ
$429B
| $339K | 0.03% |
2,161
| – | – |
|
63
Avantor
AVTR
$8.84B
| $333K | 0.03% |
14,596
| – | – |
|
64
Integra LifeSciences
IART
$1.21B
| $316K | 0.03% |
7,261
| – | – |
|
65
HCA Healthcare
HCA
$97B
| $314K | 0.03% |
1,160
| – | – |
|
66
QuidelOrtho
QDEL
$1.87B
| $314K | 0.03% |
4,257
| – | – |
|
67
Qiagen
QGEN
$10.1B
| $300K | 0.02% |
6,518
| – | – |
|
68
United Therapeutics
UTHR
$17.3B
| $296K | 0.02% |
1,345
| – | – |
|
69
Dentsply Sirona
XRAY
$2.83B
| $293K | 0.02% |
8,228
| – | – |
|
70
Biogen
BIIB
$20.3B
| $284K | 0.02% |
1,096
| – | – |
|
71
Labcorp
LH
$22.8B
| $277K | 0.02% |
1,218
| – | – |
|
|
PDCO
72
DELISTED
Patterson Companies, Inc.
PDCO
| $264K | 0.02% |
9,264
| – | – |
|
73
Revvity
RVTY
$9.8B
| $243K | 0.02% |
2,223
| – | – |
|
|
BAY
74
DELISTED
BAYER AG SPONS ADR
BAY
| $235K | 0.02% |
25,475
| – | – |
|
75
Organon & Co
OGN
$2.52B
| $183K | 0.01% |
12,716
| – | – |
|